FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2561770849> ?p ?o ?g. }

• W2561770849 abstract "Abstract Abstract 1733 Targeted therapies with tyrosine kinase inhibitors (TKI) have significantly improved the treatment of cancer patients. Ex vivo generated dendritic cells (DC) are commonly used in immunotherapeutic strategies due to their unique ability to initiate adaptive immune responses, and multiple approaches presently aim to combine targeted therapies with immunotherapy. However, as many kinases targeted by TKI are, besides governing tumor cell growth, also involved in the activation of DC, TKI therapy may cause immunoinhibitory side effects. Osteoactivin (GPNMB, DC-HIL) is a type I transmembrane glycoprotein that is detected abundantly in DC but not in monocytes. Its expression on antigen-presenting cells can inhibit T cell activation by binding syndecan-4 (SD-4) on T cells. Here we investigated the effect of the BCR/ABL TKI imatinib, dasatinib and nilotinib, which are approved for the treatment of CML, on the expression of osteoactivin and DC functions. DC were generated from blood monocytes by plastic adherence and exposure to GM-CSF and IL-4. Imatinib, nilotinib or dasatinib were added to the culture medium every second day starting from the first day of culture. In some experiments, toll-like receptor (TLR) ligands (L) (LPS (TLR4L), pam3Cys (TLR2L), poly I:C (TLR3L) or R848 (TLR7/8L) were added on day 6 of culture for maturation of DC. We found that DC generated in the presence of therapeutic concentrations of all three TKI displayed an altered phenotype. Imatinib caused significantly reduced expression of the typical DC markers CD1a, CD83 and the co-stimulatory molecule CD86. Nilotinib reduced the expression of CD1a, CD83, CD86 and the DC-specific C-type lectin receptor DC-SIGN (CD209). Dasatinib impaired expression of CD1a, CD83, CD86, CD80 and DC-SIGN. Most notably, we observed excessive up-regulation of osteoactivin on DC upon treatment with all three TKI. Interestingly, incubation with the immunosuppressive and anti-inflammatory cytokine IL-10 also resulted in osteoactivin over-expression. In line with osteoactivin up-regulation, exposure to TKI resulted in reduced stimulatory capacity of DC in MLR with allogenic T cells that could be restored by addition of blocking anti-osteoactivin antibody. In summary, our data demonstrate that up-regulation of osteoactivin is critically involved in the inhibition of DC function upon TKI exposure. These findings are of great importance for future combinatory approaches using TKI and DC-based immunotherapy and indicate that inhibition of osteoactivin expression or function may serve as a novel strategy to enhance the efficacy of immunotherapeutic interventions in cancer patients. Disclosures: No relevant conflicts of interest to declare." @default.
• W2561770849 created "2017-01-06" @default.
• W2561770849 creator A5017087069 @default.
• W2561770849 creator A5023755346 @default.
• W2561770849 creator A5026255080 @default.
• W2561770849 creator A5033134476 @default.
• W2561770849 creator A5059182746 @default.
• W2561770849 creator A5066624700 @default.
• W2561770849 creator A5085504780 @default.
• W2561770849 date "2010-11-19" @default.
• W2561770849 modified "2023-10-01" @default.
• W2561770849 title "The Immune-Inhibitory Receptor Osteoactivin Is up-Regulated In Monocyte-Derived Dendritic Cells Upon Exposure to Tyrosine Kinase Inhibitors" @default.
• W2561770849 doi "https://doi.org/10.1182/blood.v116.21.1733.1733" @default.
• W2561770849 hasPublicationYear "2010" @default.
• W2561770849 type Work @default.
• W2561770849 sameAs 2561770849 @default.
• W2561770849 citedByCount "0" @default.
• W2561770849 crossrefType "journal-article" @default.
• W2561770849 hasAuthorship W2561770849A5017087069 @default.
• W2561770849 hasAuthorship W2561770849A5023755346 @default.
• W2561770849 hasAuthorship W2561770849A5026255080 @default.
• W2561770849 hasAuthorship W2561770849A5033134476 @default.
• W2561770849 hasAuthorship W2561770849A5059182746 @default.
• W2561770849 hasAuthorship W2561770849A5066624700 @default.
• W2561770849 hasAuthorship W2561770849A5085504780 @default.
• W2561770849 hasConcept C121608353 @default.
• W2561770849 hasConcept C126322002 @default.
• W2561770849 hasConcept C185592680 @default.
• W2561770849 hasConcept C203014093 @default.
• W2561770849 hasConcept C2777413986 @default.
• W2561770849 hasConcept C2777583451 @default.
• W2561770849 hasConcept C2778170410 @default.
• W2561770849 hasConcept C2778729363 @default.
• W2561770849 hasConcept C2778820342 @default.
• W2561770849 hasConcept C2779536868 @default.
• W2561770849 hasConcept C3019892230 @default.
• W2561770849 hasConcept C42362537 @default.
• W2561770849 hasConcept C502942594 @default.
• W2561770849 hasConcept C62478195 @default.
• W2561770849 hasConcept C71924100 @default.
• W2561770849 hasConcept C86803240 @default.
• W2561770849 hasConcept C8891405 @default.
• W2561770849 hasConcept C95444343 @default.
• W2561770849 hasConcept C98274493 @default.
• W2561770849 hasConceptScore W2561770849C121608353 @default.
• W2561770849 hasConceptScore W2561770849C126322002 @default.
• W2561770849 hasConceptScore W2561770849C185592680 @default.
• W2561770849 hasConceptScore W2561770849C203014093 @default.
• W2561770849 hasConceptScore W2561770849C2777413986 @default.
• W2561770849 hasConceptScore W2561770849C2777583451 @default.
• W2561770849 hasConceptScore W2561770849C2778170410 @default.
• W2561770849 hasConceptScore W2561770849C2778729363 @default.
• W2561770849 hasConceptScore W2561770849C2778820342 @default.
• W2561770849 hasConceptScore W2561770849C2779536868 @default.
• W2561770849 hasConceptScore W2561770849C3019892230 @default.
• W2561770849 hasConceptScore W2561770849C42362537 @default.
• W2561770849 hasConceptScore W2561770849C502942594 @default.
• W2561770849 hasConceptScore W2561770849C62478195 @default.
• W2561770849 hasConceptScore W2561770849C71924100 @default.
• W2561770849 hasConceptScore W2561770849C86803240 @default.
• W2561770849 hasConceptScore W2561770849C8891405 @default.
• W2561770849 hasConceptScore W2561770849C95444343 @default.
• W2561770849 hasConceptScore W2561770849C98274493 @default.
• W2561770849 hasLocation W25617708491 @default.
• W2561770849 hasOpenAccess W2561770849 @default.
• W2561770849 hasPrimaryLocation W25617708491 @default.
• W2561770849 hasRelatedWork W113892858 @default.
• W2561770849 hasRelatedWork W2006875981 @default.
• W2561770849 hasRelatedWork W2036767300 @default.
• W2561770849 hasRelatedWork W2061990495 @default.
• W2561770849 hasRelatedWork W2079621801 @default.
• W2561770849 hasRelatedWork W2170056170 @default.
• W2561770849 hasRelatedWork W2170748847 @default.
• W2561770849 hasRelatedWork W2320505596 @default.
• W2561770849 hasRelatedWork W2324162321 @default.
• W2561770849 hasRelatedWork W2592345837 @default.
• W2561770849 hasRelatedWork W2622832912 @default.
• W2561770849 hasRelatedWork W2809059748 @default.
• W2561770849 hasRelatedWork W2892618446 @default.
• W2561770849 hasRelatedWork W2939681859 @default.
• W2561770849 hasRelatedWork W2951418942 @default.
• W2561770849 hasRelatedWork W2980176712 @default.
• W2561770849 hasRelatedWork W2987896965 @default.
• W2561770849 hasRelatedWork W3021465020 @default.
• W2561770849 hasRelatedWork W3028488454 @default.
• W2561770849 hasRelatedWork W637411693 @default.
• W2561770849 isParatext "false" @default.
• W2561770849 isRetracted "false" @default.
• W2561770849 magId "2561770849" @default.
• W2561770849 workType "article" @default.